Relief Therapeutics’ Wholly Owned Subsidiary, APR Applied Pharma Research, Launches PKU GOLIKE(R) KRUNCH in Germany and Italy
APR Expands PKU GOLIKE(R) Product Line with More Convenient, Chewable Tablet OptionGENEVA, SWITZERLAND / ACCESSWIRE / September 9, 2021 /...